131 related articles for article (PubMed ID: 7890758)
21. Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis.
Yamamoto E; Ino K; Miyoshi E; Shibata K; Takahashi N; Kajiyama H; Nawa A; Nomura S; Nagasaka T; Kikkawa F
Br J Cancer; 2007 Dec; 97(11):1538-44. PubMed ID: 17971775
[TBL] [Abstract][Full Text] [Related]
22. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection.
Yoshimura M; Nishikawa A; Ihara Y; Taniguchi S; Taniguchi N
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8754-8. PubMed ID: 7568011
[TBL] [Abstract][Full Text] [Related]
23. Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I.
Zhang W; Betel D; Schachter H
Biochem J; 2002 Jan; 361(Pt 1):153-62. PubMed ID: 11742540
[TBL] [Abstract][Full Text] [Related]
24. Effects of H-ras and v-sis overexpression on N-acetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells.
Guo HB; Zhang QS; Chen HL
J Cancer Res Clin Oncol; 2000 May; 126(5):263-70. PubMed ID: 10815761
[TBL] [Abstract][Full Text] [Related]
25. Correlated gene expression between beta-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines.
Sato T; Shirane K; Kido M; Furukawa K
Biochem Biophys Res Commun; 2000 Oct; 276(3):1019-23. PubMed ID: 11027584
[TBL] [Abstract][Full Text] [Related]
26. Gene expression of N-acetylglucosaminyltransferases III and V: a possible implication for liver regeneration.
Miyoshi E; Ihara Y; Nishikawa A; Saito H; Uozumi N; Hayashi N; Fusamoto H; Kamada T; Taniguchi N
Hepatology; 1995 Dec; 22(6):1847-55. PubMed ID: 7489997
[TBL] [Abstract][Full Text] [Related]
27. Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation.
Ito Y; Akinaga A; Yamanaka K; Nakagawa T; Kondo A; Dickson RB; Lin CY; Miyauchi A; Taniguchi N; Miyoshi E
Glycobiology; 2006 May; 16(5):368-74. PubMed ID: 16464868
[TBL] [Abstract][Full Text] [Related]
28. High expression of UDP-N-acetylglucosamine: beta-D mannoside beta-1,4-N-acetylglucosaminyltransferase III (GnT-III) in chronic myelogenous leukemia in blast crisis.
Yoshimura M; Nishikawa A; Ihara Y; Nishiura T; Nakao H; Kanayama Y; Matuzawa Y; Taniguchi N
Int J Cancer; 1995 Feb; 60(4):443-9. PubMed ID: 7829256
[TBL] [Abstract][Full Text] [Related]
29. Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor-beta. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein).
Wrana JL; Kubota T; Zhang Q; Overall CM; Aubin JE; Butler WT; Sodek J
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):523-31. PubMed ID: 1996953
[TBL] [Abstract][Full Text] [Related]
30. Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway.
Guo HB; Lee I; Bryan BT; Pierce M
J Biol Chem; 2005 Mar; 280(9):8332-42. PubMed ID: 15615721
[TBL] [Abstract][Full Text] [Related]
31. Remodeling of glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing beta1,4-N-acetylglucosaminyltransferase III.
Sheng Y; Yoshimura M; Inoue S; Oritani K; Nishiura T; Yoshida H; Ogawa M; Okajima Y; Matsuzawa Y; Taniguchi N
Int J Cancer; 1997 Dec; 73(6):850-8. PubMed ID: 9399665
[TBL] [Abstract][Full Text] [Related]
32. Expression of N-acetylglucosaminyltransferase V in the development of human esophageal cancers: immunohistochemical data from carcinomas and nearby noncancerous lesions.
Ishibashi Y; Dosaka-Akita H; Miyoshi E; Shindoh M; Miyamoto M; Kinoshita I; Miyazaki H; Itoh T; Kondo S; Nishimura M; Taniguchi N
Oncology; 2005; 69(4):301-10. PubMed ID: 16282710
[TBL] [Abstract][Full Text] [Related]
33. Molecular cloning and characterization of human GnT-IX, a novel beta1,6-N-acetylglucosaminyltransferase that is specifically expressed in the brain.
Inamori K; Endo T; Ide Y; Fujii S; Gu J; Honke K; Taniguchi N
J Biol Chem; 2003 Oct; 278(44):43102-9. PubMed ID: 12941944
[TBL] [Abstract][Full Text] [Related]
34. N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis.
Kamada Y; Mori K; Matsumoto H; Kiso S; Yoshida Y; Shinzaki S; Hiramatsu N; Ishii M; Moriwaki K; Kawada N; Takehara T; Miyoshi E
Glycobiology; 2012 Jun; 22(6):778-87. PubMed ID: 22294551
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and expression of cDNA encoding chicken UDP-N-acetyl-D-glucosamine (GlcNAc): GlcNAcbeta 1-6(GlcNAcbeta 1-2)- manalpha 1-R[GlcNAc to man]beta 1,4N-acetylglucosaminyltransferase VI.
Sakamoto Y; Taguchi T; Honke K; Korekane H; Watanabe H; Tano Y; Dohmae N; Takio K; Horii A; Taniguchi N
J Biol Chem; 2000 Nov; 275(46):36029-34. PubMed ID: 10962001
[TBL] [Abstract][Full Text] [Related]
36. Unusually high expression of N-acetylglucosaminyltransferase-IVa in human choriocarcinoma cell lines: a possible enzymatic basis of the formation of abnormal biantennary sugar chain.
Takamatsu S; Oguri S; Minowa MT; Yoshida A; Nakamura K; Takeuchi M; Kobata A
Cancer Res; 1999 Aug; 59(16):3949-53. PubMed ID: 10463590
[TBL] [Abstract][Full Text] [Related]
37. Enhanced epithelial-mesenchymal transition-like phenotype in N-acetylglucosaminyltransferase V transgenic mouse skin promotes wound healing.
Terao M; Ishikawa A; Nakahara S; Kimura A; Kato A; Moriwaki K; Kamada Y; Murota H; Taniguchi N; Katayama I; Miyoshi E
J Biol Chem; 2011 Aug; 286(32):28303-11. PubMed ID: 21697088
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
Ide Y; Miyoshi E; Nakagawa T; Gu J; Tanemura M; Nishida T; Ito T; Yamamoto H; Kozutsumi Y; Taniguchi N
Biochem Biophys Res Commun; 2006 Mar; 341(2):478-82. PubMed ID: 16434023
[TBL] [Abstract][Full Text] [Related]
39. TGF-β1 Causes EMT by Regulating N-Acetyl Glucosaminyl Transferases via Downregulation of Non Muscle Myosin II-A through JNK/P38/PI3K Pathway in Lung Cancer.
Khan GJ; Gao Y; Gu M; Wang L; Khan S; Naeem F; Semukunzi H; Roy D; Yuan S; Sun L
Curr Cancer Drug Targets; 2018; 18(2):209-219. PubMed ID: 28782471
[TBL] [Abstract][Full Text] [Related]
40. The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III.
Kang SK; Chung TW; Lee JY; Lee YC; Morton RE; Kim CH
J Biol Chem; 2004 Jul; 279(27):28106-12. PubMed ID: 15123606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
